新闻
2024-06-04
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
临床结果免疫疗法细胞疗法临床研究
2024-06-04
泽璟制药宣布递交注射用重组人促甲状腺激素生物制品上市许可申请
上市批准
2024-06-04
有望改变乳腺癌治疗模式!重磅ADC最新3期临床结果发布
临床结果ASCO会议抗体药物偶联物
2024-06-04
迪哲医药「舒沃替尼」全球注册研究达主要终点
临床结果ASCO会议上市批准
2024-06-04
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
临床结果ASCO会议抗体药物偶联物
2024-06-04
Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
临床结果免疫疗法ASCO会议临床研究
2024-06-03
辉瑞:RSV疫苗中国申报临床
疫苗信使RNA抗体药物偶联物上市批准
2024-06-03
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
免疫疗法ASCO会议临床结果引进/卖出
2024-06-03
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
临床结果上市批准疫苗
2024-06-03
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia in diabetes from European Medicines Agency
上市批准引进/卖出